Show simple item record

Osteoporosis and Osteopathy Markers in Patients with Mastocytosis

dc.contributor.authorSindel, Dilsad
dc.contributor.authorBuyukbabani, Nesimi
dc.contributor.authorKanitez, Nilufer Alpay
dc.contributor.authorTanakol, Refik
dc.contributor.authorErer, Burak
dc.contributor.authorYayuz, Akif Selim
dc.contributor.authorDogan, Oner
dc.contributor.authorBaykal, Can
dc.date.accessioned2021-03-05T22:01:15Z
dc.date.available2021-03-05T22:01:15Z
dc.date.issued2015
dc.identifier.citationKanitez N. A. , Erer B., Dogan O., Buyukbabani N., Baykal C., Sindel D., Tanakol R., Yayuz A. S. , "Osteoporosis and Osteopathy Markers in Patients with Mastocytosis", TURKISH JOURNAL OF HEMATOLOGY, cilt.32, ss.43-50, 2015
dc.identifier.issn1300-7777
dc.identifier.otherav_dba1328e-32f7-4a85-9460-fa784126d20e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144768
dc.identifier.urihttps://doi.org/10.4274/tjh.2013.0170
dc.description.abstractObjective: Osteoporosis, osteosclerosis, and lytic bone lesions have been observed in patients with systemic mastocytosis (SM). We examined bone mineral density (BMD) biochemical turnover markers and serum tryptase levels in SM, which is considered a rare disease.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleOsteoporosis and Osteopathy Markers in Patients with Mastocytosis
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF HEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume32
dc.identifier.issue1
dc.identifier.startpage43
dc.identifier.endpage50
dc.contributor.firstauthorID23405


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record